Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quest Pharmatech Inc V.QPT

Alternate Symbol(s):  QPTFF

Quest PharmaTech Inc. is a Canada-based biopharmaceutical company. The Company is developing products to improve the quality of life. The Company is also developing a proprietary MAb AR 9.6 targeting truncated MUC16 as theranostic agents for cancer. The Company has a 42.5% ownership interest in OncoQuest Inc. (OncoQuest), a Canadian biotechnology company developing combinatorial immunotherapy products for the treatment of cancer. OncoQuest’s technology platform included a panel of tumor antigen-specific monoclonal antibodies of the immunoglobulin G (IgG) and E (IgE) class targeting CA125, MUC1, PSA, Her2/neu, CA 19.9 and TAG72; and the application of combinatorial immunotherapy to enhance tumor specific immunity and clinical outcome. It also has a 23% ownership interest in OncoVent Co., Ltd. (OncoVent), which is developing antibody-based immunotherapeutic products for cancer for the Greater China territory.


TSXV:QPT - Post by User

Comment by MrMugsyon Nov 18, 2020 2:08pm
94 Views
Post# 31923686

RE:RE:RE:RE:OncoQuest Pharmaceuticals Inc. Doses First Patient in Ph 3

RE:RE:RE:RE:OncoQuest Pharmaceuticals Inc. Doses First Patient in Ph 3 The way I understand the deal, $62.5M can be liquidated by end of year.
It is represented as a fixed number so I'm assuming it will not go higher if Dual (OncoQuest) shares go higher - as is the present case.

I don't know how difficult it will be to sell the maximum allowable nor do I know if they will try to cash all the allowable out.  They will likely need to do so in a controlled manner depending on what they decide.

Quest shareholders could have access to 40-44% of that cash.  Management is contemplating what to do.  That's all I can say as I don't know how it will all play out.

------------------

Own in USD ...
We have $125M purchased at 3806.3 - can acces $62.5M by yearend.
We have $20M purchased at 3265.00.
We have $155M purchased at 3265.00

For the above, QPT owns 40-44%

------------------

Let me know if someone sees an error in the number.

Also, I see shares closed yesterday on the exchange at 5950 - It's been a nice ride up but I know nothing about this exchange.


<< Previous
Bullboard Posts
Next >>